CLEOPATRA - Roche's pertuzumab to queen it over HER2 breast cancer?
18 July 2011
Alex Shimmings
Please Login to read the full article.
18 July 2011
Alex Shimmings
alex.shimmings@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Roche's T-DM1 (Herceptin-plus) shows early benefit in first-line metastatic breast cancer
- US FDA to decide fate of Genentech's pertuzumab by 8 June
- Future subcutaneous Herceptin studies could lead to patient-administration
- Tykerb and Herceptin work better together, study suggests
ANALYSIS
Other Informa Analysis
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
